Skip to main content

Table 4 Percent change from T0 in HORAC levels in clinical study

From: Acute reduction of serum 8-iso-PGF2-alpha and advanced oxidation protein products in vivo by a polyphenol-rich beverage; a pilot clinical study with phytochemical and in vitro antioxidant characterization

  

% Change over T0

 

T0

T60

T120

T180

T240

PRB

1

55.1 ±7.19*

67.5 ±7.20*

54.5 ±6.52*

75.8 ±9.21*

Placebo

1

23.6 ±5.38

74.7 ±5.91*

44.4 ±5.81*

43.0 ±8.47

  1. *p < 0.05 as compared to T0 by paired T-test.